Afirma Genomic Test | 2024 American Association of Clinical Endocrinology | Double TERT | Patient Case Study

Afirma Genomic Test | 2023 American Thyroid Association Poster Presentation | Immunophenotyping

Afirma Genomic Test | 2023 American Thyroid Association Poster Presentation | Isthmus

Afirma Genomic Test | 2023 American Thyroid Association Poster Presentation | NIS

AMP Data: Assessment of BRAF Fusions in 177,227 Thyroid Nodules by Exome-Enriched RNA-Seq Testing

November 2024

ATA Data: Polyamine and Methionine Metabolism Gene Expression Analysis in Thyroid Tumors

November 2024

ATA Data: Distinct Molecular Profiles of Thyroid Nodules in Patients Under 21 Years of Age

November 2024

ATA Data: Clinical Performance of the Afirma Genomic Sequencing Classifier (GSC) in Pediatric Patients With Cytologically Indeterminate Thyroid Nodules

November 2024

ENDO Data – Prostate-Specific Membrane Antigen (PSMA) Expression in Cytologically Indeterminate and Malignant Thyroid Nodules

June 2024

ENDO Data – Retrospective Analysis of mRNA Expression Based Signatures of Thyroid Tumor Invasion and Metastases

June 2024

AACE Data: Efficacy of Radiofrequency Ablation for Afirma Genomic Sequencing Classifier (GSC) Benign Indeterminate Thyroid Nodules

May 2024

AACE Data: First Report of Pre-Operative Detection of Two TERT Promoter Mutations Within a Papillary Thyroid Carcinoma

May 2024

JCEM Data: Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay

May 2024

ATA Data: Sodium Iodide Symporter (NIS) Expression in Cytologically Indeterminate and Malignant Thyroid Nodules

September 2023

ATA Data: Molecular Assessment of Isthmus Thyroid Carcinomas

September 2023

ATA Data: Leveraging RNA Sequencing for Pre-Operative Immunophenotyping of BRAFV600E+ Thyroid Nodules

September 2023

ENDO Data: Cytologic and Molecular Assessment of Isthmus Thyroid Nodules

June 2023

AACE Data – Histopathology of Telomerase Reverse Transcriptase Promoter (TERT) Mutated Indeterminate Thyroid Nodules

May 2023

JCEM data – Real world performance of the Afirma Genomic Sequencing Classifier (GSC) – a meta analysis

September 2022

Thyroid – Preoperative identification of medullary thyroid carcinoma (MTC): Clinical validation of the Afirma MTC RNA-Sequencing classifier

September 2022

Cancer Cytopathology – The Afirma Xpression Atlas for Thyroid Nodules and Thyroid Cancer Metastases: Insights to Inform Clinical Decision-Making from a Fine-Needle Aspiration Sample

May 2022

ENDO Oral Data – Identification of Novel and Rare Receptor Tyrosine Kinase Fusions in Thyroid Fine Needle Aspirates

(ENDO 2020 canceled due to COVID-19)

ENDO Data – Positive Predictive Value of TP53 Variants in Bethesda III/IV Thyroid Fine-Needle Aspirates

(ENDO 2020 canceled due to COVID-19)

JCEM – Real World Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules (Cleveland Clinic)

May 2022

Cancer Cytopathology – Performance of the Afirma Genomic Sequencing Classifier Versus Gene Expression Classifier: An Institutional Experience (Fox Chase)

May 2022

Frontiers in Endocrinology – Afirma Xpression Atlas Clinical & Analytical Validation Study

May 2022

Thyroid Journal – Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules

May 2022

ASCO Data: New Afirma Data Shows Potential to Guide Targeted Treatment for Medullary Thyroid Cancer

May 2022

Thyroid Journal – Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules (B&W)

May 2022

Cancer Cytopathology – Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer

May 2022

BMC Systems Biology – Identification of Hürthle Cell Cancers: Solving a Clinical Challenge with Genomic Sequencing and a Trio of Machine Learning Algorithms

May 2022

ENDO Data – New Afirma Xpression Atlas Data Advances Genomic Understanding of Medullary Thyroid Cancer

May 2022

Endocrine Practice – Statistical Comparison of Afirma GSC and Afirma GEC Outcomes in a Community Endocrine Surgical Practice: Early Findings (Memorial Healthcare)

May 2022